4TEEN4 Pharmaceuticals Reports First Results on Procizumab, a Novel Therapeutic Anti-DPP3 Antibody for Treatment of Acute Myocardial Depression
PARIS, FRANCE, and HENNIGSDORF/BERLIN, GERMANY / ACCESSWIRE / August 31, 2019 / 4TEEN4 Pharmaceuticals GmbH ("4TEEN4", former Sphingotec Therapeutics GmbH,...